2024/2653(DEA) Examination of variations to the terms of marketing authorisations for medicinal products for human use
Lead committee dossier:
Progress: Awaiting committee decision
| Role | Committee | Rapporteur | Shadows |
|---|---|---|---|
| Lead | ENVI |
Lead committee dossier:
Events
2024/03/13
EP - Committee referral announced in Parliament
2024/03/11
EC - Non-legislative basic document
Documents
2024/03/11
EC - Document attached to the procedure
Documents
2024/03/11
EC - Non-legislative basic document published
Documents
2024/03/11
EP/CSL - Initial period for examining delegated act 3 month(s)
Documents
- Non-legislative basic document: C(2024)01627
- Document attached to the procedure: EUR-Lex
- Document attached to the procedure: SWD(2024)0058
- Non-legislative basic document published: C(2024)01627
- Non-legislative basic document: C(2024)01627
- Document attached to the procedure: EUR-Lex SWD(2024)0058